Litcius/Paper detail

Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2

Matthias Thoms, Robert Buschauer, Michael Ameismeier, Lennart Koepke, Timo Denk, Maximilian Hirschenberger, Hanna Kratzat, Manuel Hayn, Timur Mackens‐Kiani, Jingdong Cheng, Jan Hendrik Straub, Christina M. Stürzel, Thomas Fröhlich, Otto Berninghausen, Thomas Becker, Frank Kirchhoff, Konstantin M. J. Sparrer, Roland Beckmann

2020Science938 citationsDOIOpen Access PDF

Abstract

A viral block on host protein synthesis As the coronavirus disease 2019 (COVID-19) pandemic continues to cause devastation, scientists race to increase their understanding of the disease-causing severe acute respiratory syndrome coronavirus 2. Once inside host cells, not only does the virus hijack the cells' translational machinery to make viral proteins, but the virulence factor nonstructural protein 1 (Nsp1) also shuts down translation of host messenger RNA. Thoms et al. determined a 2.6-angstrom resolution cryo–electron microscopy structure of a reconstituted complex of Nsp1 bound to the human 40 S ribosomal subunit and showed that Nsp1 blocks the messenger RNA entry tunnel. A structural inventory of native Nsp1-ribosome complexes from human cells confirms this mechanism. Cellular studies show that the translational shutdown almost completely inhibits the innate immune response. The binding pocket on the ribosome may be a target for drugs to treat COVID-19. Science , this issue p. 1249

Topics & Concepts

ShutdownSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Evasion (ethics)VirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakImmune escapeImmune systemBiologyImmunologyMedicineEngineeringNuclear engineeringInfectious disease (medical specialty)PathologyDiseaseOutbreakSARS-CoV-2 and COVID-19 Researchinterferon and immune responsesViral gastroenteritis research and epidemiology
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2 | Litcius